Labcorp Holdings Inc. (LH) Earnings Per Share (EPS): 11.29
Is Labcorp Holdings Inc.’s earnings per share (EPS) high or low?
Labcorp Holdings Inc.'s earnings per share (EPS) of 11.29 is 14% below its 5-year average of 13.14, around the middle of its 5-year range (4.80–24.58).
As of Sunday, June 14, 2026. 16.21% above its 12-month average of 9.71.
LH Earnings Per Share (EPS) Chart
LH Average Earnings Per Share (EPS) Chart
LH Current vs Average Earnings Per Share (EPS) Chart
LH Earnings Per Share (EPS) Metrics
EARNINGS PER SHARE (EPS)
11.29
EARNINGS PER SHARE (EPS) AVG TTM
9.71
EARNINGS PER SHARE (EPS) AVG 3Y
9.57
EARNINGS PER SHARE (EPS) AVG 5Y
13.14
EARNINGS PER SHARE (EPS) AVG 10Y
10.90
EARNINGS PER SHARE (EPS) AVG 15Y
9.35
EARNINGS PER SHARE (EPS) AVG 20Y
8.08
CURRENT VS TTM AVG
+16.21%
CURRENT VS 3Y AVG
+18.00%
CURRENT VS 5Y AVG
-14.08%
CURRENT VS 10Y AVG
+3.57%
CURRENT VS 15Y AVG
+20.72%
CURRENT VS 20Y AVG
+39.74%
LH Competitors' Earnings Per Share (EPS)
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 11.29 | 9.71 | 9.57 | 13.14 |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 42.71 | 41.42 | 39.43 | 36.04 |
| BioNTech SE (BNTX) | $22.90B | -5.94 | -4.08 | 9.21 | 14.48 |
| United Therapeutics Corporation (UTHR) | $23.17B | 27.05 | 28.29 | 23.40 | 19.31 |
| Waters Corporation (WAT) | $23.17B | 7.87 | 10.78 | 11.05 | 10.65 |
| Moderna, Inc. (MRNA) | $19.80B | -8.15 | -8.27 | -1.90 | 3.46 |
| Veeva Systems Inc. (VEEV) | $25.92B | 5.61 | 4.98 | 4.09 | 3.61 |
| Hologic, Inc. (HOLX) | $16.97B | 2.40 | 2.92 | 3.22 | 4.07 |
| DexCom, Inc. (DXCM) | $29.08B | 2.34 | 1.80 | 1.48 | 1.30 |
| Biogen Inc. (BIIB) | $29.53B | 9.34 | 10.02 | 12.26 | 14.06 |
EPS Comparison
Trailing EPS (TTM)
$11.29
Forward EPS (Est.)
$19.49
P/E Ratio
23.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
- Directly impacts stock valuation through P/E ratio
- Used to calculate dividend coverage and payout ratios
- Enables comparison across companies of different sizes
- Growth in EPS often correlates with stock price appreciation
Labcorp Holdings Inc. Earnings Per Share (EPS) Formula & Definition
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. Earnings Per Share (EPS) FAQ
- What is the earnings per share (EPS) for Labcorp Holdings Inc. (LH)?
- The earnings per share (EPS) for LH stock is 11.29.
- Is Labcorp Holdings Inc.'s earnings per share (EPS) high or low?
- Labcorp Holdings Inc.'s earnings per share (EPS) of 11.29 is 14% below its 5-year average of 13.14, around the middle of its 5-year range (4.80–24.58).
- What is the TTM average earnings per share (EPS) for Labcorp Holdings Inc. (LH)?
- The TTM average earnings per share (EPS) for LH stock is 9.71.
- What is the 3Y average earnings per share (EPS) for Labcorp Holdings Inc. (LH)?
- The 3Y average earnings per share (EPS) for LH stock is 9.57.
- What is the 5Y average earnings per share (EPS) for Labcorp Holdings Inc. (LH)?
- The 5Y average earnings per share (EPS) for LH stock is 13.14.
- What is the 10Y average earnings per share (EPS) for Labcorp Holdings Inc. (LH)?
- The 10Y average earnings per share (EPS) for LH stock is 10.90.
- What is the 15Y average earnings per share (EPS) for Labcorp Holdings Inc. (LH)?
- The 15Y average earnings per share (EPS) for LH stock is 9.35.
- What is the 20Y average earnings per share (EPS) for Labcorp Holdings Inc. (LH)?
- The 20Y average earnings per share (EPS) for LH stock is 8.08.
Labcorp Holdings Inc. Earnings Per Share (EPS) History
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 10.54 |
| 2024-12-31 | 8.89 |
| 2023-12-31 | 4.80 |
| 2022-12-31 | 14.04 |
| 2021-12-31 | 24.58 |
| 2020-12-31 | 15.99 |
| 2019-12-31 | 8.41 |
| 2018-12-31 | 8.71 |
| 2017-12-31 | 12.39 |
| 2016-12-31 | 7.14 |
| 2015-12-31 | 4.42 |
| 2014-12-31 | 6.03 |
| 2013-12-31 | 6.70 |
| 2012-12-31 | 6.24 |
| 2011-12-31 | 5.31 |
| 2010-12-31 | 5.45 |
| 2009-12-31 | 4.98 |
| 2008-12-31 | 4.60 |
| 2007-12-31 | 4.08 |
| 2006-12-31 | 3.48 |
| 2005-12-31 | 2.89 |
| 2004-12-31 | 2.60 |
| 2003-12-31 | 2.23 |
| 2002-12-31 | 1.78 |
| 2001-12-31 | 1.29 |
| 2000-12-31 | 0.83 |
| 1999-12-31 | 0.30 |
| 1998-12-31 | 0.50 |
| 1997-12-31 | -2.17 |
| 1996-12-31 | -3.12 |
Related Metrics
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter